Platelet-to-White Blood Cell Ratio Is Associated with Adverse Outcomes in Cirrhotic Patients with Acute Deterioration.
Jung Hee KimMyoung-Kuk JangDo-Seon SongHee-Yeon KimEileen L YoonTae-Hyung KimYoung-Kul JungKi-Tae SukBaek-Gyu JunHyung-Joon YimJung-Hyun KwonSung-Won LeeSeong-Hee KangMoon-Young KimSoung-Won JeongJae-Young JangJeong-Ju YooSang Gyune KimYoung-Joo JinGab-Jin CheonByung Seok KimYeon-Seok SeoHyung-Su KimDong-Hyun SinnWoo-Jin ChungHwi-Young KimHan-Ah LeeSeung-Woo NamIn-Hee KimJung-Il SuhJi Hoon KimHee-Bok ChaeJoo-Hyun SohnJu-Yeon ChoYun Joon KimJin-Mo YangJung-Gil ParkWon KimHyun-Chin ChoDong Joon KimPublished in: Journal of clinical medicine (2022)
A lower PWR level was associated with 28-day adverse outcomes, indicating that the PWR level can be a useful and simple tool for stratifying the risk of 28-day adverse outcomes in LC patients with AD.